Investment Society Lausanne
All articles

Macro Review

Monthly Macro Review - December 2025

IS Team·1 Jan 2026· 5 min read
Monthly Macro Review - December 2025

Macro at a Glance

The EU-Mercosur trade agreement emerged as a contentious issue during December, exemplifying how fragile trade liberalization remains amid rising protectionism and tariff concerns. Despite substantial negotiating progress, formal signing was deferred to January 2026 as political leaders encountered significant domestic opposition, particularly from agricultural interests worried about competitive import pressures and differing regulatory standards. French President Emmanuel Macron expressed reservations about the current text, while Italy's Giorgia Meloni and Poland's Donald Tusk similarly voiced opposition or reservations. The broader market implication centers on trade policy's renewed role as a volatility driver, with agricultural protectionism potentially undermining major commercial agreements. 2025 has established itself as a year characterized by protectionist sentiment globally.

Bulgaria will join the eurozone as its 21st member starting January 1st, 2026, following European Commission confirmation that Sofia satisfied all convergence requirements. The lev conversion rate was established at 1.95583 per euro, maintaining a fixed parity arrangement operational since 1999 under the ERM II framework. Officials assert euro adoption will reduce transaction expenses, boost investment flows, and strengthen financial stability for the bloc's most economically disadvantaged participant. This development follows the recent resignation of Prime Minister Rosen Zhelyazkov and cabinet members amid widespread protests concerning economic governance and corruption.

Central bank policies are experiencing significant divergence. The Federal Reserve reduced rates by 25 basis points on December 10th, establishing the target range at 3.50%-3.75%. The European Central Bank maintained its benchmark rates on December 18th. The Bank of Japan elevated rates to 0.75% on December 19th, continuing its measured departure from accommodative monetary stance. January 2026 will feature significant rate-setting meetings: the Bank of Japan on the 22nd-23rd and the Federal Reserve on the 27th-28th. The ECB's subsequent rate decision occurs February 5th, though market participants will scrutinize January 22nd ECB meeting minutes for consensus strength regarding rate maintenance. This institutional divergence may generate heightened currency market volatility, particularly if Japanese rate increases continue their recent trajectory.

One Sector, One Insight

Basic Materials and Energy

Silver concluded 2025 as a striking illustration of a commodity serving dual purposes—simultaneously functioning as an industrial component (solar installations, electrification infrastructure, computing systems) and a monetary hedge during declining rate environments and geopolitical tensions. Structurally, supply remains constrained: the Silver Institute documented that 2025 appeared positioned to register a fifth successive structural deficit. The critical macroeconomic narrative from late December centered on price discovery remaining susceptible to leverage dynamics. Silver temporarily achieved unprecedented highs (exceeding $82/oz intraday) before experiencing a sudden 10% correction within a trading session—among the sharpest reversals since pandemic onset. The CME's margin increase (from $20,000 to $25,000 per contract) precipitated mechanical deleveraging.

Consumption and General Public Services

Nike's Q2 2026 results (December 18th) disappointed market sentiment despite earnings substantially exceeding forecasts. Share prices fell nearly 12% as investors examined ongoing operational challenges: a dramatic 17% sales contraction in China and persistent margin compression from promotional activities and tariff expenses. Sentiment subsequently recovered when Apple CEO Tim Cook announced a substantial personal share purchase ($3 million for 50,000 shares), prompting approximately 5% appreciation on December 24th.

Financial Services

Consumer debt delinquencies have intensified into a macroeconomic concern, with over 9 million Americans failing to maintain student loan payments—numerous accounts exhibiting severe arrears exceeding 270 days. This phenomenon may suppress consumer expenditures as borrowers prioritize debt obligations over discretionary purchases and housing investment. Default consequences extend beyond immediate payment difficulties, degrading credit profiles and restricting access to mortgages and vehicle financing. Administrative enforcement mechanisms restarted in 2025, with wage garnishment notifications anticipated for early 2026, signaling termination of pandemic-era payment suspension.

Healthcare

Novo Nordisk experienced volatile performance throughout 2025, with valuations declining 50% at one point amid intensified competitive pressures and pipeline disappointments. Market sentiment shifted on December 23rd following FDA approval of an oral Wegovy formulation (announced December 22nd), generating a 7% gain. This accomplishment afforded temporary competitive positioning advantages within the expanding obesity medication sector. However, subsequent price reductions in selected Chinese markets (December 29th) illustrated how GLP-1 therapeutics have transitioned from specialty commodities toward conventional competitive categories determined by market pricing mechanisms.

Industrials

The European Commission formally announced rescission of its complete internal combustion engine prohibition on December 18th, substituting the 2035 zero-emission mandate with a "technology-neutral" 90% emissions reduction objective. This adjustment permits continued hybrid vehicle and synthetic e-fuel automobile commercialization, representing success for German industrial advocates advocating timeline flexibility. Market reception proved underwhelming: Volkswagen declined 1% and BMW fell approximately 2% following the announcement. Investors appear concerned the policy recalibration signals weakened electrification commitment, potentially conferring technological advantage to Chinese competitors including BYD while extending legacy infrastructure investments.

Technology and Network Equipment

Warner Bros. Discovery became central to a transformative $100 billion+ competitive bidding scenario. Following WBD board approval on December 5th of asset sale to Netflix for $82.7 billion, Paramount initiated a hostile $108.4 billion all-cash counteroffer. Paramount enhanced its proposal on December 22nd with a $40 billion financing guarantee from Oracle founder Larry Ellison. Despite elevated Paramount valuation, WBD's board unanimously rejected this counterproposal on December 17th, citing regulatory complications and Netflix arrangement's superior strategic alignment, which incorporates spinning legacy network operations into a separate enterprise. WBD shares appreciated 3.6% subsequently as investors evaluated the Netflix deal's certainty against Paramount's aggressive consolidation ambitions.

Stock of the Month

Rocket Lab surged over 66% throughout December, achieving $37 billion market valuation following a secured $816 million Space Development Agency contract for 18 satellites comprising the Tracking Layer constellation. This appreciation reflected the corporation's advancing transition from commercial launch services toward defense space infrastructure capabilities. Year-end momentum and speculative positioning amplified the revaluation as market participants sought clarity regarding order pipelines and favorable defense sector expenditure dynamics.

Key Performance Metrics

Index/Asset December 31 Close Monthly Change Year-to-Date
S&P 500 6845.50 -0.05% 16.39%
Dow Jones 48063.29 0.73% 12.97%
NASDAQ 23241.99 -0.53% 20.36%
FTSE 100 9931.38 2.17% 21.51%
CAC 40 8149.50 0.33% 10.42%
DAX 24490.41 2.74% 23.01%
SMI 20 13267.48 3.38% 14.37%
MSCI World 4430.38 0.73% 19.49%
VIX 14.95 -0.43% -5.76%
CHF/USD 1.2599 1.44% 14.63%
CHF/EUR 1.0737 0.20% 0.97%
Brent Crude $60.84/bbl -3.73% -18.21%
Gold Spot $4218.30/oz 2.70% 66.23%

Upcoming Events

  • January 19-23: World Economic Forum Annual Meeting (Davos)
  • January 22-23: Bank of Japan Monetary Policy Meeting
  • January 27-28: US FOMC Meeting